A Phase II study combining short course radiotherapy, chemotherapy and resection of the rectum and metastases in primary metastasized rectal cancer.
Completed
- Conditions
- rectal cancer, primary metastasized, stage IVrectumcarcinoom, primair gemetastaseerd, stadium IV
- Registration Number
- NL-OMON27950
- Lead Sponsor
- K. Havenga, M.D. Ph.D.
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion Criteria
DISEASE CHARACTERISTICS:
1. Histologically verified adenocarcinoma of the rectum;
Exclusion Criteria
See inclusion criteria.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The percentage of complete resection or ablation (R0) of all primary and metastatic tumor.
- Secondary Outcome Measures
Name Time Method Two-year survival, two-year recurrence rate, and treatment associated toxicity.